Overexpression of Wnt-2 in colorectal cancers

Neoplasma

Volumn 56, Issue 2, 2009, Pages 119-123

  Park, J K ^a   Song, J H ^a   He, T C ^b   Nam, S W ^a   Lee, J Y ^a   Park, W S ^a  

^a The Catholic University of Korea   (South Korea)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Expression; Immunohistochemistry; Tissue microarray; Wnt 2 protein

Indexed keywords

WNT2 PROTEIN;

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; COLORECTAL CANCER; CYTOPLASM; EARLY DIAGNOSIS; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TUMOR VOLUME; UPREGULATION; CHEMISTRY; COLORECTAL TUMOR; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL RATE;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; SURVIVAL RATE; WNT2 PROTEIN;

EID: 65649112897     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_02_119     Document Type: Article

References (27)

1. DANN CE, HSIEH JC, RATTNER A, et al. Insights into Wnt binding and ignaling from the structures of two Frizzled cysteine-rich domains. Nature 2001; 412: 86-90. doi:10.1038/35083601 PMid:11452312
2. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007; 17: 45-51. doi:10.1016/j.gde.2006.12.007
3. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003; 129: 199-221. (Pubitemid 36713796)
4. PARK WS, OH RR, PARK JY, et al. Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res 1999; 59: 4257-4260. (Pubitemid 29418739)
5. RESNICK MB, ROUTHIER J, KONKIN T, et al. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 2004; 10: 3069-3075. doi:10.1158/1078-0432.ccr-03-0462 PMid:15131045
6. UTHOFF SM, EICHENBERGER MR, MCAULIFFE TL, et al. Wingless-type frizzled protein receptor signaling and its putative role in human colon cancer. Mol Carcinog 2001; 31: 56-62. doi:10.1002/mc.1039 PMid:11398198
7. KIM IJ, KU JL, KANG HC, PARK JH, et al. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients. Hum Genet 2004; 115: 498-503. doi:10.1007/s00439-004-1186-7 PMid:15449173
8. Nusse R, VARMUS HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31: 99-109. doi :10.1016/0092-8674(82)90409-3 PMid:6297757
9. Blasband A, Schryver B, Papkoff J. The biochemical properties and transforming potential of human Wnt-2 are similar to Wnt-1. Oncogene 1992; 7: 153-161.
10. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000; 287: 1606-1609. doi:10.1126/science.287. 5458.1606 PMid:10733430 (Pubitemid 30127755)
11. You L, He B, Xu Z, et al. Inhibition of Wnt2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004; 23: 6170-6174. doi:10.1038/ sj.onc.1207844 PMid:15208662 (Pubitemid 39178870)
12. BOON EM, VAN DER NEUT R, VAN DE WETERING M, et al. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 2002;62: 5126-5128.
13. Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol 2001; 19: 1003-1007.
14. HOLCOMBE RF, MARSH JL, WATERMAN ML, et al. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mod Pathol 2002; 55: 220-226. doi:10.1136/mp.55.4.220 PMid:12147710 PMCid: 1187182
15. Mazieres J, You L, He B, Xu Z, et al. Wnt2 as a new therapeutic target in malignant pleural mesothelioma. Int J Cancer 2005; 117: 326-332. doi:10.1002/ijc.21160 (Pubitemid 41377454)
16. You L, He B, Xu Z, et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res 2004; 64: 5385-5389. doi:10.1158/0008-5472.CAN-04-1227 PMid:15289346 (Pubitemid 39006560)
17. ASTLER VB, COLLER FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-851.
18. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-847. doi:10.1038/ nm0798-844 PMid:9662379 (Pubitemid 28331029)
19. CHENG XX, WANG ZC, CHEN XY, et al. Correlation of Wnt-2 expression and β-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cancer Letters 2005; 223: 339-347. doi:10.1016/j. canlet.2004.11.013 PMid:15896469
20. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25: 7531-7537. doi:10.1038/sj.onc.1210059 PMid:17143297 (Pubitemid 44885752)
21. Aguilera O, Peńa C, GARCÍA JM, et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha, 25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007; 28: 1877-1884. doi:10.1093/ carcin/bgm094 PMid:17449905 (Pubitemid 47500598)
22. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000; 60: 4366-4371. (Pubitemid 32103613)
23. Suzuki H, WATKINS DN, JAIR KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417-422. doi:10.1038/ ng1330 PMid:15034581 (Pubitemid 38437267)
24. Li J, Mizukami Y, Zhang X, et al. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK- 3beta. Gastroenterology 2005; 128: 1907-1918. doi:10.1053/j. gastro.2005.02.067 PMID:15940626 (Pubitemid 40824702)
25. Shi Y, He B, KUCHENBECKER KM, et al. Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells. Int J Cancer 2007; 121: 1175-1181. doi:10.1002/ijc. 22848 (Pubitemid 47293782)
26. Le Floch N, Rivat C, De Wever O, et al. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling. FASEB J 2005; 10: 144-146. (Pubitemid 40069946)
27. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1: 55-67. doi:10.1038/35094067 PMid:11900252 (Pubitemid 33741881)